372 filings
8-K
NRXP
NRX Pharmaceuticals Inc
19 Apr 24
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
5:10pm
424B5
NRXP
NRX Pharmaceuticals Inc
19 Apr 24
Prospectus supplement for primary offering
10:08am
424B5
NRXP
NRX Pharmaceuticals Inc
18 Apr 24
Prospectus supplement for primary offering
8:21am
8-K
NRXP
NRX Pharmaceuticals Inc
15 Apr 24
Other Events
5:22pm
424B3
NRXP
NRX Pharmaceuticals Inc
15 Apr 24
Prospectus supplement
5:13pm
424B3
pfun6b2 5czhzwy7x
15 Apr 24
Prospectus supplement
6:00am
8-K
mwn8mkmivgmhbx 2zz7n
2 Apr 24
Four potential near-term milestones, including data from two clinical trials, an NDA filing and an upcoming share dividend
6:01am
8-K
tlq7 xl740
28 Mar 24
NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
5:08pm
8-K
n9itdqn8 cg6iqudk
21 Mar 24
NRx Pharmaceuticals Announces Results of the Vote Held During the Special Meeting of Shareholders
5:09pm
DEFA14A
8xwjvsu 0z
20 Mar 24
Additional proxy soliciting materials
4:00pm
DEFA14A
ip1cn20p
18 Mar 24
Additional proxy soliciting materials
4:00pm
DEFA14A
53plm02wih4 xjr
13 Mar 24
Additional proxy soliciting materials
5:08pm
8-K
exunfjmjlalzptj
6 Mar 24
Other Events
4:08pm
8-K
ojwy3toe6e69j lxnh1a
28 Feb 24
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
5:09pm
424B5
l22 06u0dn
28 Feb 24
Prospectus supplement for primary offering
10:40am
424B5
03463o3d7rq6f62p3z
26 Feb 24
Prospectus supplement for primary offering
5:15pm
8-K
myb0cb8ndmtuxp 2f
14 Feb 24
Entry into a Material Definitive Agreement
4:30pm
8-K
uxrq58jk37yk7zdxta1
14 Feb 24
Entry into a Material Definitive Agreement
6:03am